---
title: "vVardis Holding offers more shares but prices US IPO below the range at $18"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305470713.md"
description: "vVardis Holding priced its US IPO at $18 per share, below the expected range of $21-$24, raising $175 million from 9.7 million shares. The Swiss-based company, developer of non-invasive cavity treatments like Curodont, will trade on the NYSE under symbol VVVV. This marks a significant listing event for the dental technology firm."
datetime: "2026-11-13T13:48:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305470713.md)
  - [en](https://longbridge.com/en/news/305470713.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305470713.md)
generator: "portal-rs"
---

# vVardis Holding offers more shares but prices US IPO below the range at $18

vVardis Holding, which sells proprietary non-invasive treatments for cavities, raised $175 million by offering 9.7 million shares at $18, below the $21 to $24 range. The company had planned to offer 8.3 million shares, after decreasing the deal from 9.5 million shares on 11/12.

Based in Switzerland, vVardis develops and sells Curodont, a peptide-based treatment for early-stage cavities that is applied in a dental office in five minutes or less, with no drilling or needles. Its US product, Curodont Repair Fluoride Plus, is marketed as an over-the-counter drug under an FDA monograph and generates the vast majority of revenue. A fluoride-free version, Curodont Repair, is sold as a medical device in the UK and parts of Europe.

The Zug, Switzerland-based company will trade on the NYSE under the symbol VVVV. Goldman Sachs, J.P. Morgan, William Blair, UBS Investment Bank, and Deutsche Bank acted as joint bookrunners on the deal.

### Related Stocks

- [VVVV.US](https://longbridge.com/en/quote/VVVV.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [vVARDIS Prices IPO at $18 per Share](https://longbridge.com/en/news/305725290.md)
- [Swiss dental startup vVardis shares fall in NYSE debut](https://longbridge.com/en/news/305494348.md)
- [Tech outages are causing people to panic buy. Costco is benefitting](https://longbridge.com/en/news/305992986.md)
- [Will Revenue Outlook Cut Change Lululemon Stock's Narrative](https://longbridge.com/en/news/305993397.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**